Nyxoah SA (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
7.71
-0.01 (-0.13%)
At close: Jun 5, 2025, 4:00 PM
7.49
-0.22 (-2.85%)
Pre-market: Jun 6, 2025, 4:57 AM EDT
Nyxoah Market Cap
Nyxoah has a market cap or net worth of $275.57 million as of June 6, 2025. Its market cap has decreased by -7.48% in one year.
Market Cap
275.57M
Enterprise Value
228.67M
1-Year Change
-7.48%
Ranking
Category
Stock Price
$7.71
Market Cap Chart
Since the IPO on February 9, 2021, Nyxoah's market cap has decreased from $506.14M to $275.57M, a decrease of -45.55%. That is a compound annual growth rate of -13.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2025 | 275.57M | -13.90% |
| Dec 31, 2024 | 320.06M | 137.05% |
| Dec 29, 2023 | 135.02M | -4.90% |
| Dec 30, 2022 | 141.98M | -73.96% |
| Dec 31, 2021 | 545.17M | 7.71% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.72B |
| Johnson & Johnson | 373.90B |
| AbbVie | 330.30B |
| Novo Nordisk | 323.14B |
| UnitedHealth Group | 276.42B |
| Abbott Laboratories | 232.39B |
| Novartis AG | 228.01B |
| AstraZeneca | 222.18B |